Glucose conjugation for the specific targeting and treatment of cancer

Emilia C. Calvaresi, Paul J. Hergenrother

Research output: Contribution to journalArticlepeer-review


Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis. Increased understanding of this dysfunctional metabolism known as the Warburg effect has led to an interest in targeting it for cancer therapy. One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar. This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or anticancer therapeutics have been linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity. Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.

Original languageEnglish (US)
Pages (from-to)2319-2333
Number of pages15
JournalChemical Science
Issue number6
StatePublished - May 7 2013

ASJC Scopus subject areas

  • Chemistry(all)


Dive into the research topics of 'Glucose conjugation for the specific targeting and treatment of cancer'. Together they form a unique fingerprint.

Cite this